SCHEMBL7301416

SCHEMBL7301416

O=C(N[C@H](CO)Cc1ccc(OCc2ccccc2)cc1)OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 2/20 0.64
LTA4H P09960 2/20 0.55
LAP3 P28838 1/20 0.55
ITGB3 P05106 7/20 0.55
ITGA2B P08514 7/20 0.55
PPARG P37231 2/20 0.52
PPARA Q07869 2/20 0.52
HDAC8 Q9BY41 1/20 0.52
FFAR1 O14842 1/20 0.51
FFAR4 Q5NUL3 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9484576 1.00 CTRB1 (0.64) CTRB1LTA4HLAP3ITGB3ITGA2B
SCHEMBL5551626 0.91 CTRB1 (0.60) CTRB1ITGB3ITGA2BHDAC8CYP1A2
SCHEMBL8612085 0.91 CTRB1 (0.60) CTRB1ITGB3ITGA2BHDAC8CYP1A2
SCHEMBL8612079 0.91 CTRB1 (0.60) CTRB1ITGB3ITGA2BHDAC8CYP1A2
SCHEMBL1051352 0.91 CTRB1 (0.76) CTRB1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL2482903 0.91 CTRB1 (0.76) CTRB1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL2435512 0.91 CTRB1 (0.76) CTRB1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL17931616 0.90 NPC1 (0.58) CTRB1LTA4HPPARGPPARAFFAR1
SCHEMBL3126256 0.89 ITGB3 (0.58) CTRB1ITGB3ITGA2B
SCHEMBL8775071 0.89 CTRB1 (0.57) CTRB1ITGB3ITGA2BCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5245034-A Compound having vessel smooth muscle relaxation activity Hidaka, Kiroyoshi (JP) 1993-09-14 US disclosed
US-5216150-A Muscle relaxant; enzyme inhibitor and platelet aggutination inhibitor Hidaka, Hiroyoshi (JP) 1993-06-01 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed
US-5081246-A Isoquinolino sulfonamino derivatives Hidaka, Hiroyoshi (JP) 1992-01-14 US disclosed